Vimarsana
Biggest News Aggregation in the World

Page 2 - Study Sites News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Sites. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Sites Today - Breaking & Trending Today

NIH Study Finds Flame-Retardant Chemicals May Increase Risk of Preterm Birth, Higher Birth Weight - Vimarsana News

NIH Study Finds Flame-Retardant Chemicals May Increase Risk of Preterm Birth, Higher Birth Weight

An NIH Environmental influences on Child Health Outcomes (ECHO) Cohort study finds that certain organophosphate esters (OPEs) were linked to increased odds of p

NIH Study Finds Flame-Retardant Chemicals May Increase Risk of Preterm Birth, Higher Birth Weight - Vimarsana News

NIH Study Finds Flame-Retardant Chemicals May Increase Risk of Preterm Birth, Higher Birth Weight

An NIH Environmental influences on Child Health Outcomes (ECHO) Cohort study finds that certain organophosphate esters (OPEs) were linked to increased odds of p

Theralase Technologies Inc.: Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements - Vimarsana News

Theralase Technologies Inc.: Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®

Theralase Technologies Inc.: Theralase Releases 1Q2023 Interim Financial Statements - Vimarsana News

Theralase Technologies Inc.: Theralase Releases 1Q2023 Interim Financial Statements

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development

Theralase® Releases FY2022 Audited Financial Statements - Vimarsana News

Theralase® Releases FY2022 Audited Financial Statements

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...